BACKGROUND: Calcium-dependent secretory phospholipase A(2)-IIA (sPLA(2)-IIA) in the circulation is a marker of inflammation, associated with acute and chronic disease processes. We describe a quick, sensitive and reliable microplate continuous fluorescence assay for determining sPLA(2) activity in serum. METHODS: Liposomes composed of a fluorescent probe and varying amounts of L-alpha-phosphatidylglycerol (PG) and 1,2-dioleoyl-L-alpha-phosphatidylcholine (DOPC) were used as substrates to determine the optimal protocol for sPLA(2) activity determination without interference from serum albumin and lipoproteins. RESULTS: Hydrolysis of the labeled substrate by sPLA(2)-IIA, characterized by increase in fluorescence intensity (FI) and confirmed by end-product analysis, occurred in a time-, calcium-, and protein-dependent manner. Liposomes containing 100% PG were most suitable for measurement of sPLA(2) activity without interference from serum components; LDL produced a Ca(2+)-independent increase in FI when liposomes containing DOPC were used. The assay determined that sPLA(2) activity in serum spiked with sPLA(2)-IIA and illustrated that endogenous sPLA(2) activity was markedly higher in sera from patients with sepsis than in healthy subjects. Intra-assay and inter-assay CVs were in the ranges of 1.6-8.8% and 3.0-11.5%, respectively. CONCLUSIONS: The described method has potential for rapid and sensitive screening of sPLA(2) activity in both clinical and research settings.
BACKGROUND:Calcium-dependent secretory phospholipase A(2)-IIA (sPLA(2)-IIA) in the circulation is a marker of inflammation, associated with acute and chronic disease processes. We describe a quick, sensitive and reliable microplate continuous fluorescence assay for determining sPLA(2) activity in serum. METHODS: Liposomes composed of a fluorescent probe and varying amounts of L-alpha-phosphatidylglycerol (PG) and 1,2-dioleoyl-L-alpha-phosphatidylcholine (DOPC) were used as substrates to determine the optimal protocol for sPLA(2) activity determination without interference from serum albumin and lipoproteins. RESULTS: Hydrolysis of the labeled substrate by sPLA(2)-IIA, characterized by increase in fluorescence intensity (FI) and confirmed by end-product analysis, occurred in a time-, calcium-, and protein-dependent manner. Liposomes containing 100% PG were most suitable for measurement of sPLA(2) activity without interference from serum components; LDL produced a Ca(2+)-independent increase in FI when liposomes containing DOPC were used. The assay determined that sPLA(2) activity in serum spiked with sPLA(2)-IIA and illustrated that endogenous sPLA(2) activity was markedly higher in sera from patients with sepsis than in healthy subjects. Intra-assay and inter-assay CVs were in the ranges of 1.6-8.8% and 3.0-11.5%, respectively. CONCLUSIONS: The described method has potential for rapid and sensitive screening of sPLA(2) activity in both clinical and research settings.
Authors: Joseph F Pierre; Aaron F Heneghan; Francis H C Tsao; Yoshifumi Sano; Mark A Jonker; Jiro Omata; Jinggang Lan; Kenneth A Kudsk Journal: JPEN J Parenter Enteral Nutr Date: 2011-11 Impact factor: 4.016
Authors: Jiro Omata; Joseph F Pierre; Aaron F Heneghan; Francis H C Tsao; Yoshifumi Sano; Mark A Jonker; Kenneth A Kudsk Journal: Surgery Date: 2012-06-13 Impact factor: 3.982
Authors: Joseph F Pierre; Aaron F Heneghan; Jennifer M Meudt; Michael P Shea; Christian G Krueger; Jess D Reed; Kenneth A Kudsk; Dhanansayan Shanmuganayagam Journal: J Surg Res Date: 2013-02-24 Impact factor: 2.192
Authors: Francis H C Tsao; Bryan J Culver; Joseph F Pierre; Dhanansayan Shanmuganayagam; Calvin C Patten; Keith C Meyer Journal: Comp Med Date: 2012-08 Impact factor: 0.982
Authors: Vasiliki Pappa; Karl Seydel; Sanchit Gupta; Catherine M Feintuch; Michael J Potchen; Samuel Kampondeni; Adam Goldman-Yassen; Mike Veenstra; Lillie Lopez; Ryung S Kim; Joan W Berman; Terrie Taylor; Johanna P Daily Journal: Malar J Date: 2015-12-21 Impact factor: 2.979